Kriya Therapeutics
Nachi Gupta is the Chief Innovation Officer of Kriya. Nachi is board-certified in emergency medicine. Prior to his career as a clinician, Nachi was a quantitative analyst at Brevan Howard Asset Management. He also previously held an associate staff position at MIT Lincoln Laboratories on the ballistic missile defense team. He received his MD from Brown University and completed his residency in emergency medicine at Mount Sinai Hospital in New York City. Nachi also received his Ph.D. in mathematics from Oxford University. He holds advanced degrees in computer science and mathematics, as well as undergraduate degrees in economics and engineering from the University of Pennsylvania.
This person is not in any offices
Kriya Therapeutics
2 followers
Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs.